- Home
- SNOA
SNOA
Sonoma Pharmaceuticals Inc.
as 03-31-2025 3:43pm EST
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | BOULDER |
| Market Cap: | N/A | IPO Year: | 2007 |
| Target Price: | N/A | AVG Volume (30 days): | 4.6M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.90 - $9.40 | Next Earning Date: | 02-05-2025 |
| Revenue: | $13,973,000 | Revenue Growth: | 13.51% |
| Revenue Growth (this year): | 23.89% | Revenue Growth (next year): | 25.45% |
Latest Sonoma Pharmaceuticals Inc. News
SNOA Breaking Stock News: Dive into SNOA Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain
Yahoo Finance
5 days ago
Delaware passes law designed to stop more Elon Musks from leaving state
Zacks
20 days ago
Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors
MT Newswires
20 days ago
Top Premarket Gainers
ACCESS Newswire
21 days ago
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)
ACCESS Newswire
a month ago
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
Simply Wall St.
2 months ago
Is Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Worth US$2.7 Based On Its Intrinsic Value?
Simply Wall St.
2 months ago
Sonoma Pharmaceuticals Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Compare SNOA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNOA Sonoma Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.